Nectin-4

Nectin-4

Nectin-4 분자 정보

Molecule Name
Nectin-4
분자 별명
NECTIN4,LNIR, PRR4, PVRL4
Drug Development Progress
임상 약물 수29
시판 약물 수1
최고 연구 개발 단계Approved
표적 별명
PRR4,LNIR,Nectin cell adhesion molecule 4,PVRL4,Ig superfamily receptor LNIR,Poliovirus receptor-related protein 4,NECTIN4,Poliovirus Receptor-Related 4,Nectin-4,Nectin 4,EDSS1
분자 배경
Nectin-4 (Nectin Cell Adhesion Molecule 4) is a member of the nectin family of immunoglobulin-like cell adhesion molecules. It is highly expressed during embryonic development but shows limited expression in most normal adult tissues. Nectin-4 is overexpressed in a variety of solid tumors, including bladder, breast, lung, pancreatic and ovarian cancers, and has been associated with tumor growth, invasion and metastasis. Studies have shown that Nectin-4 contributes to tumor progression through multiple signaling pathways, including PI3K/Akt signaling. Due to its restricted expression in normal tissues and elevated expression in malignant tumors, Nectin-4 has emerged as an attractive therapeutic target for cancer diagnosis and treatment.

Nectin-4 제품 목록

Species
  • Human(13)
  • Mouse(5)
  • Cynomolgus(4)
  • Rat(2)
Tag
  • His Tag(8)
  • His Tag & Avi Tag(8)
  • Fc Tag(4)
  • Fc Tag & Avi Tag(3)
  • Mouse IgG Fc Tag(1)
Host
  • HEK293(24)
Conjugate
  • Unconjugated(12)
  • Biotin-labeled(10)
  • FITC Labeled(1)
  • PE Labeled(1)
Grade
  • RUO(24)
Low Endotoxin
  • Yes(3)
  • No(21)
분자Cat. No.Product Name종Host구조순도Activity규격 및 가격
Nectin-4
Mouse Nectin-4 Protein, His Tag (MALS & BLI verified)
Mouse
HEK293
MALSSDS-PAGE
BLI

$360.00

100ug
Nectin-4
HOTAvitag
NE4-H82E7
Biotinylated Human Nectin-4 Protein, His,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISATR-FRET

$360.00

25ug
Nectin-4
Human Nectin-4 Protein, His Tag, low endotoxin (Mass Spec & MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISASPRBLI

$415.00

100ug
Nectin-4
HOTAvitag
NE4-M82E7
Biotinylated Mouse Nectin-4 Protein, His,Avitag™ (MALS verified)
Mouse
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
Nectin-4
Cynomolgus Nectin-4 Protein, Fc Tag (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$360.00

100ug
Nectin-4
Cynomolgus Nectin-4 Protein, His Tag (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISASPRBLI

$360.00

100ug
Nectin-4
Avitag
NE4-C82E5
Biotinylated Cynomolgus Nectin-4 Protein, His,Avitag™ (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
Nectin-4
Avitag
NE4-C82F6
Biotinylated Cynomolgus Nectin-4 Protein, Fc,Avitag™ (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
Nectin-4
Human Nectin-4 (32-153) Protein, His Tag (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$415.00

100ug
Nectin-4
Human Nectin-4 Protein, Mouse IgG2a Fc Tag (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$355.00

100ug
You Have Viewed 1-10 Of 24 Results
  • 1
  • 2
  • 3

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
SYS-6002SYS-6002; SYS6002; CRB-701Phase 3 ClinicalCSPC Pharmaceutical Group Ltd, Jushi Biopharmaceutical Co Ltd
Carcinoma, Transitional Cell; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms
상세
SHR-A2102SHR-A2102Phase 3 ClinicalShanghai Hengrui Pharmaceutical Co Ltd
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Metastatic breast cancer; Neoplasms; Pancreatic Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms
상세
Bulumtatug fuvedotin9MW2821; 9MW-2821; 9-MW2821; 9-MW-2821Phase 3 ClinicalMabwell (Shanghai) Bioscience Co Ltd
Carcinoma; Carcinoma, Transitional Cell; Genital Neoplasms, Female; Neoplasms; Solid tumours; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Uterine Cervical Neoplasms
상세
Zelenectide pevedotinBT-8009Phase 3 ClinicalBicycle Tx Ltd
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms
상세
BT-7480BT-7480Phase 2 ClinicalBicycle Therapeutics
Neoplasms; Solid tumours
상세
VBC-103AVZO-103; VAC-103; VBC-103; VBC103Phase 2 ClinicalVelaVigo Cayman Ltd
Carcinoma; Carcinoma, Transitional Cell; Solid tumours; Triple Negative Breast Neoplasms
상세
SC-101SC-101Phase 2 ClinicalTianjin Conjustar Biotechnology Co Ltd
Breast Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
상세
SKB-410SKB410; SKB-410; MK-3120Phase 2 ClinicalSichuan Kelun-Biotech Biopharmaceutical Co Ltd
Neoplasms; Solid tumours; Urinary Bladder Neoplasms
상세
PSMA/NKG2DL/FAP-targeted Hi-TCR-T cellsPhase 1 ClinicalShenzhen Misheng Biotechnology Co Ltd
Prostatic Neoplasms; Solid tumours
상세
BA-3361BA3361; BA-3361Phase 1 ClinicalBioatla
Neoplasms
상세
ETx-22ETx-22; LY4101174Phase 1 ClinicalEmergence Therapeutics AG
Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Esophageal Neoplasms; Lung Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Pelvic Neoplasms; Prostatic Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms
상세
EB-DT-NK-UC101EB-DT-NK-UC101Phase 1 ClinicalBeijing Biotech
Carcinoma; Carcinoma, Transitional Cell; Urethral Neoplasms; Urinary Bladder Neoplasms
상세
68Ga-Nectin-4Phase 1 ClinicalThe First Affiliated Hospital Of Soochow University
Solid tumours
상세
[64Cu]Cu-AKY-1189[64Cu]Cu-AKY-1189Phase 1 ClinicalAktis Oncology Inc
Neoplasms
상세
AKY-1189AKY-1189; [225Ac]Ac-AKY-1189; 225Ac-AKY-1189Phase 1 ClinicalAktis Oncology Inc
Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Colorectal Neoplasms; Head and Neck Neoplasms; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms
상세
AK-146-D-1AK146D1; AK-146-D1Phase 1 Clinical
Solid tumours
상세
Nectin-4 targeting antibody drug conjugate 2 (Eli Lilly and Company)Phase 1 ClinicalEli Lilly And Company
Neoplasms
상세
Nectin-4 targeting antibody drug conjugate 1 (Eli Lilly and Company)Phase 1 ClinicalEli Lilly And Company
Neoplasms
상세
XKDCT-293XKDCT-293; XKDCT293Phase 1 ClinicalShenzhen Celconta Life Science Co Ltd
Breast Neoplasms
상세
IPH-4502IPH4502; IPH-4502Phase 1 ClinicalInnate Pharma SA
Solid tumours
상세
LY-4052031LY-4052031Phase 1 ClinicalEli Lilly & Company Lilly France
Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Esophageal Neoplasms; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Pelvic Neoplasms; Prostatic Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms
상세
RNDO-564RNDO-564Phase 1 ClinicalRondo Therapeutics
Carcinoma; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms
상세
ADRX-0706ADRX-0706Phase 1 ClinicalAdcentrx Therapeutics Inc
Carcinoma; Neoplasms; Solid tumours; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms
상세
BAT-8007BAT-8007Phase 1 ClinicalBio-Thera Solutions Ltd
Solid tumours
상세
Nectin-4 targeting radiopharmaceutical program (Aktis Oncology)ClinicalAktis Oncology Inc
Solid tumours
상세
[68Ga]Ga-NOTA-RND20ClinicalRenji Hospital Affiliated To Shanghai Jiaotong University School Of Medicine
Digestive System Neoplasms
상세
[18F]F-RESCA-RND20ClinicalRenji Hospital Affiliated To Shanghai Jiaotong University School Of Medicine
Digestive System Neoplasms
상세
CT-341CT-341ClinicalShenzhen Celconta Life Science Co Ltd
Breast Neoplasms
상세
68Ga-N18868Ga-N188; 68-Ga-N-188ClinicalYunnan Baiyao Group Co Ltd
Carcinoma, Transitional Cell; Neoplasms
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Enfortumab vedotinAGS-22C3E; AGS-22C3; ASG-22CE; AGS-M6; ASG-22M6E; DLE8519RWM; ASG-22ME; AGS-22ME; AGS-22M6EApprovedAgensys Inc, Seagen IncPadcev, 备思复United StatesCarcinoma, Transitional CellAstellas Pharma Us Inc2019-12-18
Carcinoma; Carcinoma in Situ; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Transitional Cell; Colorectal Neoplasms; Endometrial Neoplasms; Intestinal Neoplasms; Kidney Neoplasms; Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms
상세
Customer Reviews
  • O***s2022-07-30
    We used this for an important reagent in discovery campaigns. This was a great product! It came sooner than expected, which was awesome because we were able to easily make deadlines! It was also high quality. We didn't have any problems with it, so I am very happy with the quality of service and product. I will definitely buy again. Thank you very much.
  • 1***82019-10-11
    I Purchased this antigen for monoclonal antibody generation and antibody screening. The purity has been test by SDS-PAGE. It has a single band and no heterologous protein. It was used for antibody screening, and the screened antibody has a good affinity with the antigen.